Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review.


Journal

Behavioural neurology
ISSN: 1875-8584
Titre abrégé: Behav Neurol
Pays: Netherlands
ID NLM: 8914585

Informations de publication

Date de publication:
2020
Historique:
received: 23 03 2020
accepted: 12 06 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 11 8 2021
Statut: epublish

Résumé

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective therapy for Parkinson's disease (PD). Nevertheless, DBS has been associated with certain nonmotor, neuropsychiatric effects such as worsening of emotion recognition from facial expressions. In order to investigate facial emotion recognition (FER) after STN DBS, we conducted a literature search of the electronic databases MEDLINE and Web of science. In this review, we analyze studies assessing FER after STN DBS in PD patients and summarize the current knowledge of the effects of STN DBS on FER. The majority of studies, which had clinical and methodological heterogeneity, showed that FER is worsening after STN DBS in PD patients, particularly for negative emotions (sadness, fear, anger, and tendency for disgust). FER worsening after STN DBS can be attributed to the functional role of the STN in limbic circuits and the interference of STN stimulation with neural networks involved in FER, including the connections of the STN with the limbic part of the basal ganglia and pre- and frontal areas. These outcomes improve our understanding of the role of the STN in the integration of motor, cognitive, and emotional aspects of behaviour in the growing field of affective neuroscience. Further studies using standardized neuropsychological measures of FER assessment and including larger cohorts are needed, in order to draw definite conclusions about the effect of STN DBS on emotional recognition and its impact on patients' quality of life.

Identifiants

pubmed: 32724481
doi: 10.1155/2020/4329297
pmc: PMC7382738
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

4329297

Informations de copyright

Copyright © 2020 S. Kalampokini et al.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest regarding the publication of this article.

Références

Arch Gen Psychiatry. 2003 Mar;60(3):296-302
pubmed: 12622663
Neurobiol Dis. 2010 Jun;38(3):338-45
pubmed: 19969083
J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):754-60
pubmed: 19465417
J Parkinsons Dis. 2014;4(1):97-110
pubmed: 24496100
Neuropsychologia. 2012 Oct;50(12):2869-79
pubmed: 22944002
J Comp Neurol. 1990 Apr 22;294(4):607-22
pubmed: 2341628
Arch Neurol. 2011 Feb;68(2):165
pubmed: 20937936
Prog Neurobiol. 2017 Apr;151:139-156
pubmed: 27412110
Brain. 2000 Oct;123 ( Pt 10):2091-108
pubmed: 11004126
Philos Trans R Soc Lond B Biol Sci. 2003 Mar 29;358(1431):561-72
pubmed: 12689381
Neuroimage. 2006 Nov 1;33(2):706-14
pubmed: 16959496
Ann Neurol. 1997 Sep;42(3):283-91
pubmed: 9307248
Ann Neurol. 2009 Dec;66(6):817-24
pubmed: 20035509
Mov Disord. 2015 Feb;30(2):128-40
pubmed: 25297382
Neuropsychologia. 2008 Sep;46(11):2796-801
pubmed: 18579165
Front Psychol. 2017 Aug 24;8:1432
pubmed: 28883803
Hum Brain Mapp. 2018 Dec;39(12):5014-5027
pubmed: 30259598
J Neurosurg. 2009 Jun;110(6):1278-82
pubmed: 19301972
Brain Struct Funct. 2015 Nov;220(6):3075-86
pubmed: 25921975
J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):202-8
pubmed: 14742588
Mov Disord. 2007 Sep 15;22(12):1722-8
pubmed: 17721929
Rev Neurol (Paris). 2008 Dec;164(12):969-76
pubmed: 18808769
Psychol Bull. 1994 Jan;115(1):102-41
pubmed: 8202574
Prog Neurobiol. 2005 Aug;76(6):393-413
pubmed: 16249050
J Nucl Med. 2002 Jun;43(6):725-32
pubmed: 12050315
Arch Neurol. 1999 Aug;56(8):997-1003
pubmed: 10448806
JAMA Neurol. 2015 Nov;72(11):1354-60
pubmed: 26409114
Sci Rep. 2017 Aug 25;7(1):9413
pubmed: 28842656
Exp Neurol. 2010 Nov;226(1):120-7
pubmed: 20713047
J Neurosci. 2008 Jun 11;28(24):6165-73
pubmed: 18550758
Neuropsychology. 2010 Mar;24(2):176-91
pubmed: 20230112
Neuropsychol Rev. 2015 Dec;25(4):398-410
pubmed: 26577509
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
Neuropsychologia. 2011 Feb;49(3):528-34
pubmed: 21184765
Cortex. 2014 Feb;51:35-45
pubmed: 24342106
Biomed Res Int. 2016;2016:3596415
pubmed: 27314016
Neurology. 2006 Jun 27;66(12):1811-6
pubmed: 16801642
Brain. 2016 Sep;139(Pt 9):2503-15
pubmed: 27412387
Mov Disord. 2018 Apr;33(4):554-567
pubmed: 29473661
Brain. 2002 Sep;125(Pt 9):1995-2004
pubmed: 12183345
Mov Disord. 2005 May;20(5):574-84
pubmed: 15645534
Nat Rev Neurol. 2019 Apr;15(4):234-242
pubmed: 30778210
Front Psychol. 2019 Dec 03;10:2638
pubmed: 31849760
Neurosci Res. 2002 Jun;43(2):111-7
pubmed: 12067746
Neurosci Biobehav Rev. 2019 Sep;104:255-267
pubmed: 31336113
Neurology. 2009 Jan 6;72(1):42-9
pubmed: 19122029
Neurosci Biobehav Rev. 2016 Dec;71:802-809
pubmed: 27810346
Lancet Neurol. 2014 Mar;13(3):287-305
pubmed: 24556007
Mov Disord. 2005 Feb;20(2):172-80
pubmed: 15382210
eNeuro. 2017 Sep 22;4(5):
pubmed: 28966978
Expert Rev Neurother. 2011 Jan;11(1):139-49
pubmed: 21158561
J Parkinsons Dis. 2017;7(2):235-245
pubmed: 28505983
Acta Neurochir (Wien). 2007 Jan;149(1):67-73; discussion 73
pubmed: 17171296
Clin Neurophysiol. 2015 Apr;126(4):653-8
pubmed: 25487910
Nat Rev Neurol. 2010 Sep;6(9):487-98
pubmed: 20680036
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
J Neurol. 2009 Feb;256(2):225-33
pubmed: 19242649
Lancet Neurol. 2009 Jan;8(1):67-81
pubmed: 19081516
Exp Neurol. 2009 Jan;215(1):20-8
pubmed: 18929561
Neuropsychologia. 2008;46(9):2300-9
pubmed: 18485422
Brain Dev. 2000 Sep;22 Suppl 1:S5-16
pubmed: 10984656
J Neurol Sci. 2009 Dec 15;287(1-2):159-71
pubmed: 19767016
Mov Disord. 2011 Feb 15;26(3):477-83
pubmed: 21287598
Brain. 2004 Jan;127(Pt 1):4-20
pubmed: 14607789
Eur Neuropsychopharmacol. 2008 Nov;18(11):835-48
pubmed: 18707851
J Neurosci. 1998 Nov 15;18(22):9539-46
pubmed: 9801390
Surg Radiol Anat. 2005 Dec;27(5):389-94
pubmed: 16160830
Neurology. 2008 Sep 2;71(10):708-13
pubmed: 18650492
Sci Rep. 2017 Mar 27;7:45260
pubmed: 28345642
J Clin Med. 2019 Aug 28;8(9):
pubmed: 31466414
Eur J Neurosci. 2006 Apr;23(7):1956-60
pubmed: 16623853
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S168-70
pubmed: 22166423
N Engl J Med. 2010 Jun 3;362(22):2077-91
pubmed: 20519680
Mov Disord. 2006 Jun;21 Suppl 14:S305-27
pubmed: 16810676
Psychiatry Res. 2009 Aug 15;168(3):242-9
pubmed: 19564050
Parkinsonism Relat Disord. 2014 Feb;20(2):166-9
pubmed: 24182523
PLoS One. 2011;6(7):e22343
pubmed: 21818311
Nat Rev Neurosci. 2010 Oct;11(10):697-709
pubmed: 20811475
Trends Neurosci. 1990 Jul;13(7):266-71
pubmed: 1695401
Neuropsychol Rev. 2015 Dec;25(4):439-54
pubmed: 26459361
J Affect Disord. 2007 Nov;103(1-3):43-62
pubmed: 17363069
Front Syst Neurosci. 2013 Oct 29;7:69
pubmed: 24194703
Mov Disord. 2011 Oct;26(12):2260-6
pubmed: 21780183
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1331-8
pubmed: 23100448
Dev Psychobiol. 2002 Apr;40(3):213-25
pubmed: 11891634
Eur J Neurosci. 2011 Apr;33(8):1519-32
pubmed: 21375599
Annu Rev Neurosci. 2008;31:359-87
pubmed: 18558860
J Neurol Sci. 2011 Nov 15;310(1-2):237-40
pubmed: 21752398
J Neurosurg Sci. 2003 Mar;47(1):40-6
pubmed: 12900731
Mov Disord. 2009 Jan 30;24(2):286-9
pubmed: 19170190
Chin Med J (Engl). 2004 Sep;117(9):1304-8
pubmed: 15377418
Brain Res Brain Res Rev. 1995 Jan;20(1):91-127
pubmed: 7711769
Neuropsychologia. 2009 Jul;47(8-9):1928-37
pubmed: 19428425
Med Hypotheses. 2009 Apr;72(4):421-6
pubmed: 19157719
Neuropsychologia. 2012 Jul;50(8):2121-8
pubmed: 22640663
Prog Brain Res. 2008;172:423-63
pubmed: 18772045
Brain Cogn. 2000 Apr;42(3):324-47
pubmed: 10753483
Parkinsons Dis. 2018 May 21;2018:9756468
pubmed: 29951186
Neurology. 2003 Jan 14;60(1):78-81
pubmed: 12525722
Neurosci Lett. 2003 Apr 24;341(1):57-60
pubmed: 12676343
Nat Rev Neurosci. 2007 Aug;8(8):623-35
pubmed: 17637800
Trends Cogn Sci. 2012 Sep;16(9):458-66
pubmed: 22890089
Neurobiol Dis. 2015 Oct;82:342-348
pubmed: 26206409
Brain. 2008 Oct;131(Pt 10):2720-8
pubmed: 18941146
Clin Interv Aging. 2016 Jun 21;11:777-86
pubmed: 27382262
Brain Res Brain Res Rev. 1995 Jan;20(1):128-54
pubmed: 7711765
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):3116-21
pubmed: 25713375
Mov Disord. 2004 Dec;19(12):1463-9
pubmed: 15390065
Neurology. 2005 Sep 13;65(5):707-13
pubmed: 16157903
Braz J Med Biol Res. 2008 Apr;41(4):263-9
pubmed: 18392448
J Neurosci. 2010 Feb 10;30(6):2356-64
pubmed: 20147561
Neuropsychologia. 2010 Jun;48(7):1901-13
pubmed: 20230847
Eur J Neurosci. 2001 Apr;13(8):1609-16
pubmed: 11328354
Mov Disord. 2010 Aug 15;25(11):1583-9
pubmed: 20589868
Vitam Horm. 2010;82:47-63
pubmed: 20472132
Behav Neurosci. 2000 Feb;114(1):150-7
pubmed: 10718270
Soc Cogn Affect Neurosci. 2016 Feb;11(2):349-56
pubmed: 26400857
J Neural Transm (Vienna). 2017 Aug;124(8):907-914
pubmed: 28028643
Neuropsychologia. 2013 Sep;51(11):2051-61
pubmed: 23880097
Neurology. 2002 May 28;58(10):1546-50
pubmed: 12034798
J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):701-7
pubmed: 12023409
Front Aging Neurosci. 2015 Jan 21;6:349
pubmed: 25653616
Biol Psychiatry. 2003 Mar 15;53(6):494-501
pubmed: 12644354
J Int Neuropsychol Soc. 2010 Sep;16(5):867-76
pubmed: 20663240
Behav Cogn Neurosci Rev. 2002 Mar;1(1):21-62
pubmed: 17715585
Curr Opin Behav Sci. 2018 Feb;19:19-25
pubmed: 29915794
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):648-50
pubmed: 15026519
Front Psychol. 2017 Dec 19;8:2181
pubmed: 29312053
Neurosci Biobehav Rev. 2013 Mar;37(3):358-73
pubmed: 23318227
Curr Opin Neurobiol. 2002 Apr;12(2):169-77
pubmed: 12015233
Brain Res. 1990 Apr 9;513(1):43-59
pubmed: 2350684
Brain. 2002 Mar;125(Pt 3):575-83
pubmed: 11872614
J Neurol. 2015 Nov;262(11):2583-95
pubmed: 26037016
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17087-92
pubmed: 17942692
J Neurosci. 1996 Dec 1;16(23):7678-87
pubmed: 8922424
Brain. 2008 Jun;131(Pt 6):1599-608
pubmed: 18490359
J Neurosci. 2003 Mar 1;23(5):1916-23
pubmed: 12629196
Behav Brain Sci. 2010 Dec;33(6):417-33; discussion 433-80
pubmed: 21211115
Neuroimage. 2002 Jun;16(2):331-48
pubmed: 12030820
Parkinsonism Relat Disord. 2014 May;20(5):564-5
pubmed: 24582074
J Cereb Blood Flow Metab. 2004 Jan;24(1):7-16
pubmed: 14688612
Trends Neurosci. 2007 Jul;30(7):357-64
pubmed: 17532060
J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):952-4
pubmed: 18403439
J Neurol. 2010 Mar;257(3):375-82
pubmed: 19774437
J Neurosci. 2013 Mar 13;33(11):4804-14
pubmed: 23486951
Neurosci Biobehav Rev. 2008;32(4):863-81
pubmed: 18276008
Psychol Res. 2004 Dec;69(1-2):22-9
pubmed: 14648224
J Neurosci. 1996 Apr 15;16(8):2671-83
pubmed: 8786443
Eur J Neurosci. 2007 Aug;26(3):767-74
pubmed: 17686048
Neuropsychologia. 2005;43(7):1054-9
pubmed: 15769491
J Neurol Sci. 2012 Mar 15;314(1-2):143-51
pubmed: 22050951
Eur J Neurosci. 2007 Feb;25(4):1187-94
pubmed: 17331214
J Cogn Neurosci. 2010 Dec;22(12):2864-85
pubmed: 19929758
Trends Neurosci. 2011 Dec;34(12):611-8
pubmed: 22018805
Neural Netw. 2006 Oct;19(8):1120-36
pubmed: 16945502
Neuropsychology. 2010 Jan;24(1):1-8
pubmed: 20063943
Prog Brain Res. 1990;85:119-46
pubmed: 2094891
J Clin Neurophysiol. 2004 Jan-Feb;21(1):6-17
pubmed: 15097290
Neuroimage. 2012 Mar;60(1):83-94
pubmed: 22173294
Lancet Neurol. 2006 Jul;5(7):578-88
pubmed: 16781988
Neuroimage. 2004 Mar;21(3):1155-66
pubmed: 15006682
Brain Res Bull. 2008 Jul 30;76(5):512-21
pubmed: 18534260
J Neurosci. 2002 Oct 15;22(20):9099-103
pubmed: 12388617
JAMA Neurol. 2015 Aug;72(8):863-73
pubmed: 26076039

Auteurs

S Kalampokini (S)

Department of Neurology, University Hospital of Saarland, Kirrberger Straße, 66421 Homburg, Germany.

E Lyros (E)

Department of Neurology, University Hospital of Saarland, Kirrberger Straße, 66421 Homburg, Germany.

P Lochner (P)

Department of Neurology, University Hospital of Saarland, Kirrberger Straße, 66421 Homburg, Germany.

K Fassbender (K)

Department of Neurology, University Hospital of Saarland, Kirrberger Straße, 66421 Homburg, Germany.

M M Unger (MM)

Department of Neurology, University Hospital of Saarland, Kirrberger Straße, 66421 Homburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH